Iris Acquisition Corp /
Liminatus Pharma, LLC
Iris Acquisition Corp completed its deal for Liminatus Pharma, LLC.




What happened
The deal for Liminatus Pharma, LLC has closed, with Iris Acquisition Corp as the buyer, at a stated price of $175.0 million.
The filing from Liminatus Pharma, Inc. is dated June 2, 2025.
The source
Everything on this page comes from the source below.
Iris Acquisition Corp completed its deal for Liminatus Pharma, LLC.
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly